文献速递主动脉疾病

伴高风险特征的急性B型主动脉夹层患者的结局

Outcomes of Patients with Acute Type B Aortic Dissection and High-Risk Features.
PubMed 文献 · Ann Vasc Surg · 2024-04-02

单中心回顾性分析2011年10月至2020年3月收治的159例急性B型主动脉夹层患者,按STS/SVS 2020指南分为高风险、复杂型和非复杂型。高风险患者接受TEVAR或药物治疗结局均可接受;因复杂型TBAD行TEVAR者围术期结局和死亡率差于高风险TEVAR者。

要点

  • 159例急性TBAD中63例(40%)符合高风险标准,其中38例(60%)行TEVAR、25例(40%)药物治疗。
  • 复杂型TBAD住院时间12天(IQR 9-22)长于高风险TEVAR组11.5天(IQR 7-15)、高风险药物组6天(IQR 5-8)和非复杂组7天(IQR 5-10)(P<0.01)。
  • 复杂型TBAD 3年生存率差于其他组(log-rank P<0.01),排除住院死亡后各组生存相似(P=0.37)。

核心结论

  • 按更新版SVS/STS指南定义的高风险特征在急性TBAD患者中常见。
  • 高风险患者接受手术或药物治疗结局均可接受。
  • 因复杂型TBAD行TEVAR者围术期结局和死亡率差于高风险TEVAR者,该发现可能有助于术前风险分层和患者咨询。

研究设计与样本

  • 单中心学术医疗中心回顾性分析2011年10月至2020年3月收治的急性TBAD患者。
  • 共纳入159例急性TBAD患者,按STS/SVS 2020指南分为高风险、复杂型和非复杂型。
  • 高风险定义为难治性疼痛/高血压、血性胸腔积液、主动脉直径>4 cm、假腔直径>22 mm、影像学灌注不良和早期再入院。
  • 复杂型定义为破裂/灌注不良表现;非复杂型为无灌注不良/破裂且无高风险特征。

主要发现

  • 159例中63例(40%)符合高风险标准;高风险组中38例(60%)行TEVAR(HR-TEVAR),难治性疼痛为最常见指征,25例(40%)药物治疗(HR-medical)。
  • 灌注不良或破裂者63例(40%)为复杂型TBAD(C-TBAD),均行TEVAR;另33例无高风险特征者均为非复杂型TBAD并药物治疗。
  • 各组年龄、体重指数和种族无差异;性别、保险状态及充血性心力衰竭、慢性阻塞性肺疾病和肾功能不全等基线合并症分布不同(P<0.05)。
  • C-TBAD住院时间12天(IQR 9-22)长于HR-TEVAR 11.5天(IQR 7-15)、HR-medical 6天(IQR 5-8)和非复杂TBAD 7天(IQR 5-10)(P<0.01)。
  • C-TBAD入院至修复时间0天(IQR 0-2)短于HR-TEVAR 3.5天(IQR 1-8)(P<0.01);C-TBAD 3年生存差于其他组(log-rank P<0.01),排除住院死亡后各组生存相似(P=0.37)。

关键数值与推荐

  • 高风险标准:难治性疼痛/高血压、血性胸腔积液、主动脉直径>4 cm、假腔直径>22 mm、影像学灌注不良、早期再入院。
  • 复杂型标准:破裂/灌注不良表现。
  • 初始药物治疗者中,HR-medical组6例(24%)、非复杂组4例(12%)后续行门诊TEVAR,两组干预率无差异(P=0.22)。

临床怎么用

  • 对急性TBAD可按STS/SVS 2020指南识别高风险特征以进行风险分层。
  • 高风险患者接受TEVAR或药物治疗结局均可接受。
  • 因复杂型TBAD行TEVAR者围术期结局和死亡率差于高风险TEVAR者,可用于术前风险分层和患者咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recently the Society for Vascular Surgery (SVS) and Society for Thoracic Surgeons (STS) published contemporary guidelines clearly defining complicated versus uncomplicated acute type B aortic dissections (TBADs) with an additional high-risk grouping. Few studies have evaluated outcomes associated with "high-risk" TBADs. The objective of this study was to assess differences in demographics, clinical presentation, symptom onset, and outcomes in high-risk patients that underwent either thoracic endovascular aortic repair (TEVAR) or best medical management for acute TBAD compared to those with complicated and uncomplicated acute TBAD. METHODS: Patients admitted with acute TBADs from a single academic medical center from October 2011 to March 2020 were analyzed. Per the STS/SVS 2020 guidelines, high risk was defined as refractory pain/hypertension, bloody pleural effusion, aortic diameter >4 cm, false lumen diameter >22 mm, radiographic malperfusion, and early readmission, and complicated was defined as ruptured/malperfusion presentation. Uncomplicated patients were those without malperfusion/rupture and without high-risk features. The primary end-point was inpatient mortality. Secondary end-points included complications, reintervention, and survival. RESULTS: Of the 159 patients identified with acute TBAD, 63 (40%) met the high-risk criteria. In the high-risk cohort, 38 (60%) underwent TEVAR (HR-TEVAR), with refractory pain as the most common indication, while 25 (40%) were managed medically (HR-medical). Malperfusion or rupture was present in 63 (40%) patients (complicated TBAD (C-TBAD)), all of whom underwent TEVAR. An additional 33 patients had no high-risk features and were all managed medically (uncomplicated TBAD). There were no differences in age, body mass index, and race between groups. Among the 4 groups, there were variable distributions in sex, insurance status, and incidence of several baseline comorbidities including congestive heart failure, chronic obstructive pulmonary disease, and renal dysfunction (P < 0.05 for all). C-TBAD had increased length of stay (12, interquartile range [IQR] 9-22) compared to HR-TEVAR (11.5, IQR 7-15), HR-medical (6, IQR 5-8), and uncomplicated TBAD (7, IQR 5-10) (P < 0.01). C-TBAD had decreased days from admission to repair (0, IQR 0-2) compared to HR-TEVAR (3.5, IQR 1-8) (P < 0.01). C-TBAD patients had worse 3-year survival compared to other groups (log-rank P < 0.01), although when in-hospital mortality was excluded, survival was similar among groups (P = 0.37). Of patients initially managed medically, outpatient TEVAR was performed in 6 (24%) HR-medical and 4 (12%) uncomplicated patients, with no difference between rate of intervention between groups (P = 0.22). CONCLUSIONS: High-risk features, as defined in updated SVS/STS guidelines, are common in patients presenting with acute TBAD. High-risk patients had acceptable outcomes when managed either surgically or medically. High-risk patients that underwent TEVAR had improved perioperative outcomes and mortality compared to those undergoing TEVAR for C-TBAD, a finding which may help guide preoperative risk stratification and patient counseling.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Krebs JR, Filiberto AC, Fazzone B, et al. Outcomes of Patients with Acute Type B Aortic Dissection and High-Risk Features. Ann Vasc Surg. 2024. PMID: 38574807. doi:10.1016/j.avsg.2024.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。